The Effect of Thrombomodulin on the Cleavage of Fibrinogen and Fibrinogen Fragments by Thrombin
Overview
Authors
Affiliations
Thrombomodulin acts as a linear competitive inhibitor of thrombin with respect to the substrate fibrinogen. In the present study the effect of thrombomodulin on the activity of thrombin with fragments of the A alpha and B beta chain of fibrinogen has been examined. The cleavage of fibrinopeptide A from the N-terminal disulphide knot, fragment 1-44 and fragment 1-51 of the A alpha chain was inhibited by thrombomodulin. The average value for the inhibition constant obtained with these substrates was 0.83 +/- 0.09 nM, which was in good agreement with the values obtained previously for the inhibition of thrombin by thrombomodulin with native fibrinogen as the substrate [Hofsteenge, J., Taguchi, H. & Stone, S. R. (1986) Biochem. J. 237, 243-251]. In contrast, the cleavage of fibrinopeptide A from fragment 1-23 and fragment 1-29 of the A alpha chain was not affected by thrombomodulin. Although the cleavage of the B beta chain in the intact fibrinogen molecule was inhibited by thrombomodulin [Hofsteenge, J., Taguchi, H. & Stone, S. R. (1986) Biochem. J. 237, 243-251], the release of fibrinopeptide B from the N-terminal disulphide knot and the N-terminal 118-residue fragment of the B beta chain was not inhibited by thrombomodulin. In addition, we determined the second-order rate constants of cleavage of these substrates using human thrombin. Fragments of the A alpha chain whose cleavage was inhibited by thrombomodulin were found to have values for kcat/Km that were within one order of magnitude of that for the native fibrinogen, whereas those for A alpha chain fragments whose cleavage was not inhibited by thrombomodulin were found to be more than two orders of magnitudes lower. From these results we conclude that only a relatively small portion of the A alpha chain of the fibrinogen molecule is responsible for the specific binding to thrombin that is affected by thrombomodulin. Moreover, residues 30-44 of the A alpha chain play an important role in this thrombin-fibrinogen interaction.
Troisi R, Balasco N, Autiero I, Vitagliano L, Sica F Int J Mol Sci. 2021; 22(19).
PMID: 34639143 PMC: 8509272. DOI: 10.3390/ijms221910803.
Thrombin inhibitors from different animals.
Tanaka-Azevedo A, Morais-Zani K, Torquato R, Tanaka A J Biomed Biotechnol. 2010; 2010:641025.
PMID: 20976270 PMC: 2953280. DOI: 10.1155/2010/641025.
Regulation of the protein C anticoagulant and antiinflammatory pathways.
Rezaie A Curr Med Chem. 2010; 17(19):2059-69.
PMID: 20423310 PMC: 2904412. DOI: 10.2174/092986710791233706.
Shinshi H, Wenzler H, Neuhaus J, Felix G, Hofsteenge J, Meins F Proc Natl Acad Sci U S A. 1988; 85(15):5541-5.
PMID: 16593965 PMC: 281794. DOI: 10.1073/pnas.85.15.5541.
Evidence for common structural changes in thrombin induced by active-site or exosite binding.
Parry M, Stone S, Hofsteenge J, Jackman M Biochem J. 1993; 290 ( Pt 3):665-70.
PMID: 8457193 PMC: 1132332. DOI: 10.1042/bj2900665.